Journal
CANCER LETTERS
Volume 409, Issue -, Pages 81-90Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2017.08.039
Keywords
Hepatocellular carcinoma; Heat shock transcription factor 1; Autophagy related 4B; Protective autophagy; Epirubicin
Categories
Funding
- National Natural Science Foundation of China [31501061, 31671464, 81572375]
- Natural Science Foundation of Chongqing [cstc2017jcyjBX0079]
Ask authors/readers for more resources
Considerable evidences have shown that both heat shock transcription factor 1 (HSF1) and autophagy can attenuate the sensitivity of hepatocellular carcinoma (HCC) cells to chemotherapeutic reagents. However, it is still little known whether HSF1 is associated with autophagy in regulating the chemosensitivity of HCC cells. In this study, we for the first time demonstrated that HSF1 markedly attenuated the killing effect of epirubicin (EPI) to HCC cells via enhancing the EPI-induced protective autophagy. Mechanistically, HSF1 upregulated autophagy related 4B (ATG4B) in HCC cells, which enhanced the EPI-triggered protective autophagy. Reporter assay showed that HSF1 increased the transcriptional activity of ATG4B gene promoter, and chromatin immunoprecipitation assay verified that HSF1 bound to the site (-1429 to -1417) in ATG4B gene promoter region. The experiments in nude mice showed that knockdown of HSF1 or ATG4B strengthened the anti-HCC effect of EPI in vivo. Collectively, these results revealed that HSF1 elevates ATG4B via promoting its transcription, which alleviates the sensitivity of EPI in HCC cells through enhancing protective autophagy, suggesting that the HSF1/ATG4B/protective autophagy pathway may be a novel target for developing sensitizing strategy to HCC chemotherapy. (C) 2017 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available